Market Tracker

07/23 9:04am ET

Neurocrine Biosciences Inc (NASDAQ:NBIX)

13.55
Data as of Jul 22
 +0.38 / +2.89%
Today’s Change
8.57
Today|||52-Week Range
20.29
+45.07%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close13.17
Today’s open13.26
Day’s range-- - --
Volume524,818
Average volume (3 months)526,685
Market cap$1.0B
Dividend yield--
Data as of 07/22/2014

Growth & Valuation

Earnings growth (last year)-962.50%
Earnings growth (this year)-15.04%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-94.51%
P/E ratioNM
Price/Sales214.35
Price/Book7.58

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...-2.31-4.49%
HZNPHorizon Pharma Inc+0.08+0.57%
USNAUSANA Health Science...+4.71+6.93%
TBPHTheravance Biopharma...+0.25+0.78%
Data as of 07/22/2014

Financials

Next reporting dateJuly 30, 2014
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$2.9M
Annual profit (last year)-$46.1M
Net profit margin-1,578.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin C. Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts